Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma

This study has been completed.

Study NCT00073736 Information provided by Ligand Pharmaceuticals

First Received: December 3, 2003 Last Updated: August 10, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	July 2007 (Final data collection date for primary outcome measure)